StockNews.com initiated coverage on shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) in a report released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Several other equities analysts also recently commented on the company. Royal Bank of Canada upped their price objective on Aurinia Pharmaceuticals from $11.00 to […]
Innovis Asset Management LLC Sells 29,853 Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) – Equities research analysts at HC Wainwright lifted their Q3 2023 earnings per share estimates for shares of Aurinia Pharmaceuticals in a research report issued on Monday, August 7th. HC Wainwright analyst E. Arce now anticipates that the biotechnology company will post earnings per share of ($0.14) […]
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) – Investment analysts at HC Wainwright boosted their Q3 2023 earnings estimates for Aurinia Pharmaceuticals in a report issued on Monday, August 7th. HC Wainwright analyst E. Arce now expects that the biotechnology company will post earnings of ($0.14) per share for the quarter, up from their […]
Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) had its target price increased by HC Wainwright from $14.00 to $15.00 in a research note released on Monday morning, MarketBeat Ratings reports. They currently have a buy rating on the biotechnology company’s stock. A number of other equities analysts have also weighed in on the stock. Royal […]